Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-008505

Chief Executive Officer acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2018-02-06 Grant or award +65,000 808,675 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2018-02-06 Grant or award · Employee Stock Option (Right to Buy) +130,000 130,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…